There is a trial of strength at the cellular level. Cells are in constant competition with each other and so eliminate ...

AstraZeneca has entered into a definitive agreement to acquire EsoBiotec, a biotechnology company pioneering in vivo cell therapies that has demonstrated promising early clinical activity. The ...